The U.S. Department of Health and Human Services (HHS) has announced plans to speed up approvals and monitoring for federally funded clinical trials. The planned revisions (the first since 1981) are intended to ease the regulatory burden faced by U.S. physicians acting as clinical investigators. HHS unveiled its “Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators” in the July 26 Federal Register.
(more…)
August 29th, 2011